Boston Cambridge Biotech Trending News

Biogen Drops Ionis-Partnered Assets in ALS, Angelman Syndrome After Early-Stage Readouts

Pictured: Biogen’s signage at its headquarters in Massachusetts/iStock, JHVEPhoto Biogen and Ionis Pharmaceuticals on Thursday revealed early results from the Phase I/II ALSpire study, demonstrating that their investigational antisense oligonucleotide BIIB105 failed to significantly lower […]

No Picture
News

Erasca Announces Pricing of Underwritten Offering of Common Stock

SAN DIEGO, May 16, 2024 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced the pricing […]

Los Angeles Biotech Trending News

FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

Breakthrough DLL3-Targeting Therapy Regimen for a Major Solid Tumor IMDELLTRA Demonstrated Impressive 40% Objective Response Rate, 9.7 Month Median Duration of Response and 14.3 Month Median Overall Survival in Pivotal DeLLphi-301 Study Amgen to Host […]

News

Meet TBJ’s 2024 Life Sciences Awards winners

The Life Sciences Awards recognize individuals and research organizations that are blazing trails and breaking ground in this field. Click here to view original post Click Here to Publish/Feature Your Company or Product News with […]